JR 4 Putrii
JR 4 Putrii
JR 4 Putrii
WEDNESDAY,MAY 13 2020
Hypothesized
that circadian rhythmicity might change in association with disease course and reflect
the disease activity of CH
Aimed
investigate the pattern of circadian rhythmicity in relation to disease progression. In
CH patients participating in a prospective, multicenter registry study, the prevalence
and characteristics of circadian rhythmicity were compared between patients with
different numbers of total lifetime bouts.
Methods
Study design
circadian rhythmicity of the current bout was determined by investigators by asking patients if
their attacks in the current bout had a trend toward occurring at the same time of day
patients were observed without preventive or transitional treatment for more than 1 week (at
least 2 weeks of observation was recommended if available) and the presence of circadian
rhythmicity and time of CH attacks were ascertained at visit
Patients with 2 lifetime bouts were asked if they experienced any change in the pattern of cir-
cadian rhythmicity during their disease course.
9
Discussion
• ) the prevalence of circadian rhythmicity did not differ
according to the disease progression, although circadian
rhythmicity was less frequently reported in patients with
the longest disease duration;
The main findings • ) in half of all patients with CH, circadian rhythmicity was
not fixed, but varied from bout to bout; and
• ) the pattern of circadian rhythmicity differed according
to the disease Course
study
• First, most of the data were obtained from
patients’ recall of the current bout. This
problem is attributed to two issues: The
lack of definition of circadian rhythmicity
in CH and the ethical issue. Currently, cir-
cadian rhythmicity has not been defined
from a consensus, and it is unknown
whether the circadian rhythmicity occurs
exactly on a 24-hour basis.
• Second, our observational study can only